Delos Capital

Asia, Hong Kong Island, Hong Kong, Central

Description

A healthcare-focused private equity firm based in Hong Kong, investing in growth platforms.

Investor Profile

Delos Capital has made 8 investments, with 2 in the past 12 months and 38% as lead.

Stage Focus

Series B (63%)
Series A (25%)
Series C (13%)

Country Focus

United States (100%)

Industry Focus

Biotechnology
Biopharma
Therapeutics
Health Care
Medical
Manufacturing
Pharmaceutical
Medical Device
Bioinformatics

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Delos Capital frequently co-invest with?

Fonds de solidarité FTQ

North America, Quebec, Canada, Montréal

Co-Investments: 2

Altium Capital

North America, New York, United States, New York

Co-Investments: 2

Domain Associates

North America, California, United States, San Diego

Co-Investments: 3

Avego Bioscience Capital

North America, Georgia, United States, Alpharetta

Co-Investments: 2

Adage Capital Management

North America, Massachusetts, United States, Boston

Co-Investments: 2

Lumira Ventures

North America, Ontario, Canada, Toronto

Co-Investments: 3

Amzak Health Investors

North America, New York, United States, New York

Co-Investments: 2

CAM Capital

North America, New York, United States, New York

Co-Investments: 3

Sixty Degree Capital

North America, Ontario, Canada, Toronto

Co-Investments: 3

Aisling Capital

North America, New York, United States, New York

Co-Investments: 2

What are some of recent deals done by Delos Capital?

TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology

Series BNov 13, 2024

Amount Raised: $84,000,000

Exsilio Therapeutics

Boston, Massachusetts, United States

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Biotechnology

Series AJun 25, 2024

Amount Raised: $82,000,000

Sirius Therapeutics

San Diego, California, United States

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

BiotechnologyPharmaceuticalTherapeutics

Series BOct 9, 2023

Amount Raised: $60,000,000

Ostial Corporation

Campbell, California, United States

Ostial Corporation develops an ostial system designed to help overcome the challenges of aorto-ostial stenting.

Health CareManufacturingMedical

Series CSep 16, 2022

Amount Raised: $7,500,000

Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics

Series BNov 3, 2021

Amount Raised: $75,000,000

Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics

Series BApr 12, 2021

Amount Raised: $96,000,000

Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics

Series ANov 27, 2018

Amount Raised: $25,000,000

Atia Vision

Campbell, California, United States

Atia Medical focuses on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals.

BiotechnologyHealth CareMedicalMedical Device

Series BMay 12, 2015

Amount Raised: $3,000,000

Delos Capital

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Delos Capital frequently co-invest with?

What are some of recent deals done by Delos Capital?

Ready to Raise Capital?

Pages

Free tools